Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa

OBJECTIVE: To estimate the potential impact of using hormonal contraceptives on rates of infection with human immunodeficiency virus type 1 (HIV-1) and pregnancy by theoretically removing the use of hormonal contraceptives from a study population. METHODS: A prospective cohort study included 3704 HI...

Full description

Bibliographic Details
Main Authors: Gita Ramjee, Handan Wand
Format: Article
Language:English
Published: The World Health Organization 2012-10-01
Series:Bulletin of the World Health Organization
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012001000009&lng=en&tlng=en
_version_ 1797288286124769280
author Gita Ramjee
Handan Wand
author_facet Gita Ramjee
Handan Wand
author_sort Gita Ramjee
collection DOAJ
description OBJECTIVE: To estimate the potential impact of using hormonal contraceptives on rates of infection with human immunodeficiency virus type 1 (HIV-1) and pregnancy by theoretically removing the use of hormonal contraceptives from a study population. METHODS: A prospective cohort study included 3704 HIV-negative women who were enrolled in two biomedical trials that tested two vaginal microbicides (PRO 2000 and Carraguard®) for the prevention of HIV-1 in Durban, South Africa, in 2004-2009. Cox proportional hazards regression models along with partial population attributable risks (PARs) and their 95% confidence intervals (CIs) were calculated to assess the relative population-level impact of the use of hormonal contraceptives on HIV-1 seroconversion rates and on pregnancy rates. FINDINGS: Women who reported using hormonal contraceptives at enrolment in the trial had a higher risk of HIV-1 seroconversion (adjusted hazards ratio: 1.24; 95% CI: 0.97-1.58) than women who reported using other types of contraceptives at enrolment. At the population level, the use of hormonal contraceptives (pills or injectables) at baseline and during study follow-up accounted for approximately 20% (95% CI: 16-22) of HIV-1 seroconversions. However, the partial PAR indicated a relative impact of 12% (95% CI: 9.0-15.7). On the other hand, 72% (95% CI: 66-77) of the pregnancies could have been avoided if all women had used hormonal contraceptives. CONCLUSION: Women using hormonal contraceptives need comprehensive counselling on simultaneous prevention of HIV-1 infection.
first_indexed 2024-03-07T18:47:05Z
format Article
id doaj.art-2bcb4cabfb95436fb4ff60aa7751af46
institution Directory Open Access Journal
issn 0042-9686
language English
last_indexed 2024-03-07T18:47:05Z
publishDate 2012-10-01
publisher The World Health Organization
record_format Article
series Bulletin of the World Health Organization
spelling doaj.art-2bcb4cabfb95436fb4ff60aa7751af462024-03-02T02:19:58ZengThe World Health OrganizationBulletin of the World Health Organization0042-96862012-10-01901074875510.2471/BLT.12.105700S0042-96862012001000009Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South AfricaGita Ramjee0Handan Wand1Medical Research CouncilUniversity of New South WalesOBJECTIVE: To estimate the potential impact of using hormonal contraceptives on rates of infection with human immunodeficiency virus type 1 (HIV-1) and pregnancy by theoretically removing the use of hormonal contraceptives from a study population. METHODS: A prospective cohort study included 3704 HIV-negative women who were enrolled in two biomedical trials that tested two vaginal microbicides (PRO 2000 and Carraguard®) for the prevention of HIV-1 in Durban, South Africa, in 2004-2009. Cox proportional hazards regression models along with partial population attributable risks (PARs) and their 95% confidence intervals (CIs) were calculated to assess the relative population-level impact of the use of hormonal contraceptives on HIV-1 seroconversion rates and on pregnancy rates. FINDINGS: Women who reported using hormonal contraceptives at enrolment in the trial had a higher risk of HIV-1 seroconversion (adjusted hazards ratio: 1.24; 95% CI: 0.97-1.58) than women who reported using other types of contraceptives at enrolment. At the population level, the use of hormonal contraceptives (pills or injectables) at baseline and during study follow-up accounted for approximately 20% (95% CI: 16-22) of HIV-1 seroconversions. However, the partial PAR indicated a relative impact of 12% (95% CI: 9.0-15.7). On the other hand, 72% (95% CI: 66-77) of the pregnancies could have been avoided if all women had used hormonal contraceptives. CONCLUSION: Women using hormonal contraceptives need comprehensive counselling on simultaneous prevention of HIV-1 infection.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012001000009&lng=en&tlng=en
spellingShingle Gita Ramjee
Handan Wand
Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa
Bulletin of the World Health Organization
title Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa
title_full Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa
title_fullStr Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa
title_full_unstemmed Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa
title_short Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa
title_sort population level impact of hormonal contraception on incidence of hiv infection and pregnancy in women in durban south africa
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862012001000009&lng=en&tlng=en
work_keys_str_mv AT gitaramjee populationlevelimpactofhormonalcontraceptiononincidenceofhivinfectionandpregnancyinwomenindurbansouthafrica
AT handanwand populationlevelimpactofhormonalcontraceptiononincidenceofhivinfectionandpregnancyinwomenindurbansouthafrica